David C. Kasper

Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project

David McHugh, Cynthia A. Cameron, José E. Abdenur et al. · Genetics in Medicine · 2011 · 352 citations · Full text

Medicine, Biochemistry, Mass Spectrometric Analysis +16

Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria

Thomas P. Mechtler, Thomas Metz, Víctor R. De Jesús et al. · The Lancet · 2012 · 298 citations

Public Health, Child Health, Pediatrics +16

Quantitative PCR Method for Sensitive Detection of Ruminant Fecal Pollution in Freshwater and Evaluation of This Method in Alpine Karstic Regions

Georg H. Reischer, David C. Kasper, Ralf Steinborn et al. · Applied and Environmental Microbiology · 2006 · 199 citations · Full text

Life Sciences, Animal Sciences, Microbiology +11

A quantitative real-time PCR assay for the highly sensitive and specific detection of human faecal influence in spring water from a large alpine catchment area

Georg H. Reischer, David C. Kasper, Ralf Steinborn et al. · Letters in Applied Microbiology · 2007 · 132 citations

Life Sciences, Environmental Sciences, Microbiology +13

Plasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes

Albina Nowak, Thomas P. Mechtler, Robert J. Desnick et al. · Molecular Genetics and Metabolism · 2016 · 129 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17